TapewireFind a company

person · Reporting owner

Ramade Gregoire

Disclosed activity across 2 companies

Tapewire entity
63229
SEC CIK
0001752887

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Inogen IncINGN · Entity 2083Chief Commercial OfficerFebruary 27, 2026March 03, 2026
VAPOTHERM INCVAPO · Entity 87270SVP & Chief Commercial OfficerJanuary 02, 2023January 04, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Inogen Inc

Report date February 27, 2026 · Filed March 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect44,229 Ending reported balance After 2026-03-01 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-03-01 · Exercise / conversion · Acquired 13,005 · Balance 50,251

Row 2 · 2026-03-01 · Tax withholding · Disposed 6,022 · Balance 44,229

F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2026.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect20,000 Reported balance After 2026-02-27 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-02-27 · Grant · Acquired 20,000 · Balance 20,000

F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect26,010 Reported balance After 2026-03-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2026-03-01 · Exercise / conversion · Acquired 13,005 · Balance 26,010

F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F4: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.

Filing footnotes · ownership attribution and instrument terms

F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2026.

F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.

F4: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.

VAPOTHERM INC

Report date January 02, 2023 · Filed January 04, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect88,434 Reported balance After 2023-01-02 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-01-02 · Grant · Acquired 5,320 · Balance 88,434

F1: Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.

F2: Includes 58,553 shares that will be issued over time upon vesting and settlement of restricted stock unit awards.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.70 · Expires 2033-01-02Direct54,675 Reported balance After 2023-01-02 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2023-01-02 · Grant · Acquired 54,675 · Balance 54,675

F3: This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.

F2: Includes 58,553 shares that will be issued over time upon vesting and settlement of restricted stock unit awards.

F3: This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2026 Filed Mar 3, 2026 21:58 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionRestricted Stock Unit · Derivative 13,005 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088594 · ownership.xml · derivative · entry 4

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,010

Underlying: Common Stock · 13,005 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F4 · derivative.exercise_date: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.

F4 · derivative.expiration_date: 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:58 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 6,022 $6.10 $36,734.20
Disclosure

SEC source: 0001193125-26-088594 · ownership.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,229

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2026.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 21:58 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionCommon Stock 13,005 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088594 · ownership.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,251

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:58 UTC Inogen Inc INGN · Entity 2083 GrantRestricted Stock Unit · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088594 · ownership.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 21:08 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionRestricted Stock Unit · Derivative 31,566 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-305257 · ownership.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,565

Underlying: Common Stock · 31,566 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 21:08 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 12,943 $6.95 $89,953.85
Disclosure

SEC source: 0001193125-25-305257 · ownership.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,246

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2025.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 21:08 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionCommon Stock 31,566 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-305257 · ownership.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:44 UTC Inogen Inc INGN · Entity 2083 GrantRestricted Stock Unit · Derivative 39,015 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032645 · ownership.xml · derivative · entry 1

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,015

Underlying: Common Stock · 39,015 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:05 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionRestricted Stock Unit · Derivative 31,565 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-132856 · ownership.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,131

Underlying: Common Stock · 31,565 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:05 UTC Inogen Inc INGN · Entity 2083 Tax withholdingCommon Stock 12,942 $9.71 $125,666.82
Disclosure

SEC source: 0000950170-24-132856 · ownership.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,623

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2024.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 22:05 UTC Inogen Inc INGN · Entity 2083 Exercise / conversionCommon Stock 31,565 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-132856 · ownership.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,565

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2023 Filed Jan 4, 2023 17:49 UTC VAPOTHERM INC VAPO · Entity 87270 GrantStock Option (right to buy) · Derivative 54,675 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001235802-23-000006 · primary_doc.xml · derivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,675

Underlying: Common Stock · 54,675 shares

Expires 2033-01-02

F3 · derivative.exercise_date: This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.

Read SEC document
January 02, 2023 Filed Jan 4, 2023 17:49 UTC VAPOTHERM INC VAPO · Entity 87270 GrantCommon Stock 5,320 $2.70 $14,364.00
Disclosure

SEC source: 0001235802-23-000006 · primary_doc.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,434

F1 · shares: Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.

F1 · price: Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.

F2 · balance_after: Includes 58,553 shares that will be issued over time upon vesting and settlement of restricted stock unit awards.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 16:28 UTC VAPOTHERM INC VAPO · Entity 87270 PurchaseCommon Stock 10,000 $0.54 $5,399.00
Disclosure

SEC source: 0001235802-22-000123 · primary_doc.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,114

F1 · balance_after: Includes 59,900 shares that will be issued over time upon vesting and settlement of restricted stock units granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Plan and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 16:34 UTC VAPOTHERM INC VAPO · Entity 87270 GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001235802-22-000118 · primary_doc.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,114

F1 · shares: This award was granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (as amended from time to time, the "2018 Equity Plan") in the form of restricted stock units. The restricted stock units vest with respect to approximately one-third of the underlying shares on each of the one-year, two-year and three-year anniversaries of the grant date, subject to the Reporting Person's continued service as an employee or other service provider to the Issuer through the vesting dates.

F2 · balance_after: Includes 59,900 shares that will be issued over time upon vesting and settlement of restricted stock units granted under the 2018 Equity Plan and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan.

Read SEC document
May 10, 2022 Filed May 12, 2022 21:30 UTC VAPOTHERM INC VAPO · Entity 87270 GrantStock Option (right to buy) · Derivative 53,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0001235802-22-000064 · primary_doc.xml · derivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP and Chief Comm Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,000

Underlying: Common Stock · 53,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.

Read SEC document
January 01, 2022 Filed Jan 4, 2022 16:49 UTC VAPOTHERM INC VAPO · Entity 87270 GrantOption to Purchase Common Stock · Derivative 25,000 $0.00 Strike: $20.71 $0.00
Disclosure

SEC source: 0001235802-22-000005 · primary_doc.xml · derivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-01-01

F3 · derivative.exercise_date: This option was granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan and will vest as to 25% of the underlying shares on January 1, 2023, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the Reporting Person's continued service as an employee or other service provider to the Issuer through the vesting dates.

Read SEC document
January 01, 2022 Filed Jan 4, 2022 16:49 UTC VAPOTHERM INC VAPO · Entity 87270 GrantCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0001235802-22-000005 · primary_doc.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,114

F1 · shares: This award was granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan in the form of restricted stock units. The restricted stock units vest with respect to approximately one-third of the underlying shares on each of the one-year, two-year and three-year anniversaries of the grant date, subject to the Reporting Person's continued service as an employee or other service provider to the Issuer through the vesting dates.

F2 · balance_after: Includes 19,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 16:35 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to Purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001790300-21-000014 · primary_doc.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 16:35 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $25.03 $50,060.00
Disclosure

SEC source: 0001790300-21-000014 · primary_doc.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,614

F1 · kind: These shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 9,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 16:35 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 2,000 $3.78 $7,560.00
Disclosure

SEC source: 0001790300-21-000014 · primary_doc.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Includes 9,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.

Read SEC document
September 21, 2021 Filed Sep 22, 2021 16:51 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to Purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001235802-21-000121 · primary_doc.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
September 21, 2021 Filed Sep 22, 2021 16:51 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $27.48 $54,960.00
Disclosure

SEC source: 0001235802-21-000121 · primary_doc.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,614

F2 · kind: These shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F1 · balance_after: Includes 9,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.

Read SEC document
September 21, 2021 Filed Sep 22, 2021 16:51 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 2,000 $3.78 $7,560.00
Disclosure

SEC source: 0001235802-21-000121 · primary_doc.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 9,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.

Read SEC document
August 20, 2021 Filed Aug 23, 2021 16:16 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to Purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001235802-21-000110 · primary_doc.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 20, 2021 Filed Aug 23, 2021 16:16 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $25.31 $50,620.00
Disclosure

SEC source: 0001235802-21-000110 · primary_doc.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,614

F1 · kind: These shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 9,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.

Read SEC document
August 20, 2021 Filed Aug 23, 2021 16:16 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 2,000 $3.78 $7,560.00
Disclosure

SEC source: 0001235802-21-000110 · primary_doc.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Includes 9,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.

Read SEC document
July 28, 2021 Filed Jul 29, 2021 16:26 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to Purchase Common Stock · Derivative 8,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001235802-21-000090 · primary_doc.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,458

Underlying: Common Stock · 8,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
July 28, 2021 Filed Jul 29, 2021 16:26 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 8,000 $25.00 $200,000.00
Disclosure

SEC source: 0001235802-21-000090 · primary_doc.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,614

F1 · kind: These shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 9,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.

Read SEC document
July 28, 2021 Filed Jul 29, 2021 16:26 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 8,000 $3.78 $30,240.00
Disclosure

SEC source: 0001235802-21-000090 · primary_doc.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Includes 9,900 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.

Read SEC document
March 22, 2021 Filed Mar 23, 2021 16:06 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001562180-21-002407 · primarydocument.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested.

Read SEC document
March 22, 2021 Filed Mar 23, 2021 16:06 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $25.82 $51,640.00
Disclosure

SEC source: 0001562180-21-002407 · primarydocument.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,614

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document
March 22, 2021 Filed Mar 23, 2021 16:06 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 2,000 $3.78 $7,560.00
Disclosure

SEC source: 0001562180-21-002407 · primarydocument.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2021 Filed Feb 22, 2021 16:09 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001562180-21-001361 · primarydocument.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested.

Read SEC document
February 22, 2021 Filed Feb 22, 2021 16:09 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $27.91 $55,820.00
Disclosure

SEC source: 0001562180-21-001361 · primarydocument.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,614

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document
February 22, 2021 Filed Feb 22, 2021 16:09 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 2,000 $3.78 $7,560.00
Disclosure

SEC source: 0001562180-21-001361 · primarydocument.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 20, 2021 Filed Jan 20, 2021 16:10 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001562180-21-000378 · primarydocument.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested.

Read SEC document
January 20, 2021 Filed Jan 20, 2021 16:10 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $31.92 $63,840.00
Disclosure

SEC source: 0001562180-21-000378 · primarydocument.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,614

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document
January 20, 2021 Filed Jan 20, 2021 16:10 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 2,000 $3.78 $7,560.00
Disclosure

SEC source: 0001562180-21-000378 · primarydocument.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 20, 2021 Filed Apr 27, 2021 16:37 UTC VAPOTHERM INC VAPO · Entity 87270 OtherEmployee Stock Option (right to buy) · Derivative 11,375 $0.00 Strike: $12.16 $0.00
Disclosure

SEC source: 0001235802-21-000024 · primary_doc.xml · derivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,375

Underlying: Common Stock · 11,375 shares

Expires 2030-01-01

F2 · kind: On January 1, 2020, the Reporting Person was granted a performance-based option under the Vapotherm, Inc. 2018 Equity Incentive Plan, the actual number of underlying shares of which was not ascertainable until determined by the Issuer's Compensation Committee after completion of the one-year performance period based on the Issuer's achievement of certain pre-determined performance goals for the year ended December 31, 2020. Once vested based on performance, the stock option would then be subject to additional time-based vesting.

F3 · kind: On January 20, 2021, the Issuer's Compensation Committee determined based on 2020 performance that the performance goals were achieved at a 100% level, resulting in an option to purchase a total of 11,375 shares for the Reporting Person, with the first 25% tranche vesting on that day and the remaining 75% to vest in 36 nearly equal monthly installments thereafter, provided the Reporting Person continues to serve as an employee or other service provider to the Issuer through the applicable vesting date.

F2 · derivative.exercise_date: On January 1, 2020, the Reporting Person was granted a performance-based option under the Vapotherm, Inc. 2018 Equity Incentive Plan, the actual number of underlying shares of which was not ascertainable until determined by the Issuer's Compensation Committee after completion of the one-year performance period based on the Issuer's achievement of certain pre-determined performance goals for the year ended December 31, 2020. Once vested based on performance, the stock option would then be subject to additional time-based vesting.

F3 · derivative.exercise_date: On January 20, 2021, the Issuer's Compensation Committee determined based on 2020 performance that the performance goals were achieved at a 100% level, resulting in an option to purchase a total of 11,375 shares for the Reporting Person, with the first 25% tranche vesting on that day and the remaining 75% to vest in 36 nearly equal monthly installments thereafter, provided the Reporting Person continues to serve as an employee or other service provider to the Issuer through the applicable vesting date.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:10 UTC VAPOTHERM INC VAPO · Entity 87270 GrantStock Options (Right to buy) · Derivative 15,000 $0.00 Strike: $26.52 $0.00
Disclosure

SEC source: 0001562180-21-000084 · primarydocument.xml · derivative · entry 2

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-01-01

F2 · derivative.exercise_date: This option is eligible to vest as to 25% of the underlying shares on January 1, 2022 and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Company's applicable equity incentive plan.

Read SEC document
January 01, 2021 Filed Jan 5, 2021 16:10 UTC VAPOTHERM INC VAPO · Entity 87270 GrantCommon Stock 7,500 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000084 · primarydocument.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · SVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,614

F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's equity incentive plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest 100% on the third anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
December 21, 2020 Filed Dec 21, 2020 16:03 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001562180-20-007390 · primarydocument.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested.

Read SEC document
December 21, 2020 Filed Dec 21, 2020 16:03 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $27.65 $55,300.00
Disclosure

SEC source: 0001562180-20-007390 · primarydocument.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,114

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document
December 21, 2020 Filed Dec 21, 2020 16:03 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 2,000 $3.78 $7,560.00
Disclosure

SEC source: 0001562180-20-007390 · primarydocument.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 20, 2020 Filed Nov 20, 2020 16:30 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001562180-20-006820 · primarydocument.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested.

Read SEC document
November 20, 2020 Filed Nov 20, 2020 16:30 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $25.92 $51,840.00
Disclosure

SEC source: 0001562180-20-006820 · primarydocument.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,114

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document
November 20, 2020 Filed Nov 20, 2020 16:30 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionCommon Stock 2,000 $3.78 $7,560.00
Disclosure

SEC source: 0001562180-20-006820 · primarydocument.xml · nonDerivative · entry 1

Ramade Gregoire · CIK 0001752887 · Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 20, 2020 Filed Oct 22, 2020 16:02 UTC VAPOTHERM INC VAPO · Entity 87270 Exercise / conversionOption to purchase Common Stock · Derivative 2,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001562180-20-006414 · primarydocument.xml · derivative · entry 3

Ramade Gregoire · CIK 0001752887 · Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,458

Underlying: Common Stock · 2,000 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option is fully vested.

Read SEC document
October 20, 2020 Filed Oct 22, 2020 16:02 UTC VAPOTHERM INC VAPO · Entity 87270 SaleCommon Stock 2,000 $30.62 $61,240.00
Disclosure

SEC source: 0001562180-20-006414 · primarydocument.xml · nonDerivative · entry 2

Ramade Gregoire · CIK 0001752887 · Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,114

F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.